產(chǎn)品詳情
簡單介紹：
Anti-Bovine Fibrinogen抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Bovine Fibrinogen抗體用于**組化實驗,WB實驗,相應(yīng)的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-Bovine Fibrinogen
Cat. Number:
Anti-Bovine Fibrinogen抗體KL-10361R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Fibrinogen is the main protein of blood coagulation system. It is a large protein and it consists of two identical subunits that contain three polypeptide chains: alpha, beta and gamma. All chains are connected with each other by a number of disulfide bonds. Fibrinopeptides A (1 to 16 amino acids) and B (1 to 17 amino acids) are released by thrombin from the N terminal parts of alpha and beta chains, respectively. In this way Anti-Bovine Fibrinogen抗體fibrinogen is converted into fibrin, which by means of polymerization forms a fibrin clot. Fibrinogen clotting underlies pathogenesis of MI, thromboembolism and thromboses of arteries and veins, since fibrin is the main substrate for thrombus formation. Fibrinogen activation is also involved in pathogenesis of inflammation, tumor growth and many other diseases. The normal fibrinogen concentration in plasma is about 3 mg/ml. The elevated level of fibrinogen in patient's blood is regarded as an independent risk factor for cardiovascular diseases. An increase in blood fibrinogen concentration was shown to be a strong predictor of coronary heart disease (Sonel A. et al, and Rapold H.J. et al). All these facts make fibrinogen an important parameter in the diagnosis of cardiovascular diseases.
Also known as:
FGA; FGA protein; FGB; FGG; Fib2; Anti-Bovine Fibrinogen抗體Fibrin alpha chain ;Fibrinogen A alpha polypeptide; Fibrinogen A alpha polypeptide chain; Fibrinogen alpha chain; Fibrinogen B alpha polypeptide; Fibrinogen beta chain; Fibrinogen G alpha polypeptide; Fibrinogen gamma chain; MGC104327; MGC119422; MGC119423; MGC119425; MGC120405.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Cow, Bovine, .
●
Immunogen: Fibrinogen from bovine plasma.
Storage:
Shipped at 4℃, Store at -20℃Anti-Bovine Fibrinogen抗體 (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must beAnti-Bovine Fibrinogen抗體 determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must beAnti-Bovine Fibrinogen抗體 determined by the end user.
kl637Hu01 氨基己糖苷酶Bβ(HEXβ)多克隆抗體 Polyclonal Antibody to Hexosaminidase B Beta (HEXb)
kl637Mu01 氨基己糖苷酶Bβ(HEXβ)多克隆抗體 Polyclonal Antibody to Hexosaminidase B Beta (HEXb)
kl637Ra01 氨基己糖苷酶Bβ(HEXβ)多克隆抗體 Polyclonal Antibody to Hexosaminidase B Beta (HEXb)
kl638Bo01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl638Hu01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl638Mu01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl638Ra01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl642Ra01 果糖二磷酸醛縮酶A(ALDOA)多克隆抗體 Polyclonal Antibody to Aldolase A, Fructose Bisphosphate (ALDOA)
kl644Hu01 CCAAT增強子結(jié)合蛋白α(CEBPα)多克隆抗體 Polyclonal Antibody to CCAAT/Enhancer Binding Protein Alpha (CEBPa)
kl645Hu01 晚期糖基化終末產(chǎn)物受體(AGER)多克隆抗體 Polyclonal Antibody to Advanced Glycosylation End Product Specific Receptor (AGER)
kl645Mu01 晚期糖基化終末產(chǎn)物受體(AGER)多克隆抗體 Polyclonal Antibody to Advanced Glycosylation End Product Specific Receptor (AGER)
kl646Hu01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl646Mu01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl646Ra01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl647Hu01 Smad同源物1(Smad1)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 1 (Smad1)
kl647Ra01 Smad同源物1(Smad1)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 1 (Smad1)
